Genentech

Email this page to a friend

Want news about Genentech and more e-mailed to you? Click here for free email alerts

Too Profitable to Cure Brent Hoadley, Ph.D. See book keywords and concepts

A month later, he quit his job as a UC-SF professor and went to work for genentech. The bottom line is Seeburg created the possibilities for rDNA insulin while working at UC-SF.2 On September 6, 1978, genentech, Inc., and the City of Hope National Medical Center (a private research institution and hospital) announced the successful laboratory production of human insulin. Understand, no mention was made of the UC-SF connection.

Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs Melody Petersen See book keywords and concepts

The company genentech was giving away a video game titled Growth City. The ad firm that created the game for genentech said it worked better than an advertisement. "This ad works wonders because, well, it's not an ad," explained the staff at GSW Worldwide. The goal of the video game, they said, was to get "toddlers to teens . . . immersed in the right solutions.

Most of the schools and parents did not learn that the two foundations had received most of their funding for the school screenings from genentech and another hormone manufacturer. The foundations said they were not promoting the drugs, but only trying to get children treatment. Since then, the Magic Foundation had continued to accept money from genentech and other corporate sellers of hormones to supplement the membership dues and donations from the public that it receives.

Too Profitable to Cure Brent Hoadley, Ph.D. See book keywords and concepts

The next step in Genentech's questionable ethics and launch of a biotech business is clouded because the next partner sued for payments related to further patents and development of molecular genetic technology.3 The situation becomes even murkier and the greed obviously more profound when, as explained by Sherrie F. Nachman in the American Lawyer, genentech and Eli Lilly sue each other over intellectual property rights connected to rDNA insulins and growth hormones. The two companies agreed to disagree about property rights, opting first and foremost to concentrate on generating wealth.

In the early 1980s a company called genentech was venturing into the first rDNA programs. It was reported that as a fledgling company, genentech encouraged an employee —a researcher at a tax-supported university — to steal the original cultures used by the company. These cultures, and the employee's former position at the university, gave him knowledge and access to the cultures, setting the entire process in motion. Obfuscating this tale of theft and deception, Eli Lilly entered the picture, securing the rights to the process of rDNA insulin-production for themselves.

On September 6, 1978, genentech, Inc., and the City of Hope National Medical Center (a private research institution and hospital) announced the successful laboratory production of human insulin. Understand, no mention was made of the UC-SF connection. The next step in Genentech's questionable ethics and launch of a biotech business is clouded because the next partner sued for payments related to further patents and development of molecular genetic technology.3 The situation becomes even murkier and the greed obviously more profound when, as explained by Sherrie F.

You Don't Have to be Afraid of Cancer Anymore Bill Sardi See book keywords and concepts

When it was announced that the new anti-cancer drug Avas-tin, when combined with chemotherapy, resulted in lung cancer patients living four months longer, Genentech's stock rose dramatically and nearly $17 billion was pumped into the company. [Associated Press, March 29, 2005] Commercial interests dominate the cancer industry today. Most cancer patients are oblivious to how they have become pawns for Wall Street. If a real cure for cancer was discovered, Wall Street would collapse. Drug stocks prop up the entire stock market.

Too Profitable to Cure Brent Hoadley, Ph.D. See book keywords and concepts

It was reported that as a fledgling company, genentech encouraged an employee —a researcher at a tax-supported university — to steal the original cultures used by the company. These cultures, and the employee's former position at the university, gave him knowledge and access to the cultures, setting the entire process in motion. Obfuscating this tale of theft and deception, Eli Lilly entered the picture, securing the rights to the process of rDNA insulin-production for themselves.

What's In Your Milk?: An Exposé of Industry and Government Cover-Up on the Dangers of the Genetically Engineered (rBGH) Milk You're Drinking Samuel S. Epstein, M.D. See book keywords and concepts

BGH was subsequently synthesized by genentech Inc. 1981: genentech sold rBGH rights to Monsanto Co. 1982: Monsanto commenced long term milk production (efficacy) trials on cows injected daily with rBGH. In the same year, the FDA commenced review of Monsanto files on health effects of rBGH. 1985: With FDA approval, Monsanto initiated large-scale efficacy trials on rBGH, in close collaboration with indentured scientists in nationwide land grant Colleges and Universities, with sale of rBGH milk to the uninformed public.

Big Pharma: Exposing the Global Healthcare Agenda Jacky Law See book keywords and concepts

If they do well, however, they can do very well indeed. genentech, for example, has developed a number of new cancer drugs, including Avastin. In a letter to stockholders in its 2004 annual report, CEO Arthur D. Levinson boasted how total operating revenues had increased to $4-6 billion, more than doubling since 2001. 'Out financial position also remains strong, with approximately $2.8 billion in unrestricted cash and investments,' he added.42 One of the reasons genentech, which is now 60% owned by Roche of Switzerland, has done well is that it takes risks to nurture cteativity.

Timeless Secrets of Health & Rejuvenation: Unleash The Natural Healing Power That Lies Dormant Within You Andreas Moritz See book keywords and concepts

The research is sponsored by government agencies such as National Institute of Allergy and Infectious Diseases and National Institute of Child Health and Human Development, and huge pharmaceutical companies such as Glaxo, Pfizer, Squibb and genentech. One of the studies, "The Effect of Anti-HIV Treatment on Body Characteristics of HIV-infected Children" seeks to identify the causes of "Wasting and Lipodystrophy [fat redistribution]" by using drugs known to cause wasting and lipodystrophy.

Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs Melody Petersen See book keywords and concepts

Both these drugs were made by genentech, which posted a rise in profit in 2005 and 2006 of more than 60 percent a year. And Mr. Brennan's company, AstraZeneca, had been charging $1,800 a month for a cancer drug called Iressa when federal researchers stopped a study of the drug because it was doing nothing to lengthen lives. AstraZeneca made almost $400 million in 2004 by selling this ineffective drug, which was also blamed for killing dozens of patients with its side effects.

Since then, the Magic Foundation had continued to accept money from genentech and other corporate sellers of hormones to supplement the membership dues and donations from the public that it receives. The foundation also had continued to recommend hormone injections to short children and their parents and describe the drugs in ways the manufacturers could not do without breaking the law. A story published in the foundation's glossy magazine that I picked up at a pediatricians' conference in 2005 was entitled "Me and My Growth Hormone." The story began, "I was short.

The ad firm that created the game for genentech said it worked better than an advertisement. "This ad works wonders because, well, it's not an ad," explained the staff at GSW Worldwide. The goal of the video game, they said, was to get "toddlers to teens . . . immersed in the right solutions." Not to be outdone, Pfizer, the maker of another brand of growth hormone, had created a storybook featuring a puppy called Max, as well as a cuddly toy version of the dog, which children could use to practice injecting themselves with the drug.

What's In Your Milk?: An Exposé of Industry and Government Cover-Up on the Dangers of the Genetically Engineered (rBGH) Milk You're Drinking Samuel S. Epstein, M.D. See book keywords and concepts

Beier, former head of government affairs for genentech, which patented rBGH and sold its rights to Monsanto, now Chief Domestic Policy Advisor to Vice President Gore. ¦ Carol Tucker Foreman, Monsanto Biotech Lobbyist and Director of the Agribusiness Industry Funded Public Voice to Clinton's Global Consultative Forum as the "Consumer Advocate." ¦ L. Val Giddings, former USDA biotechnology regulator negotiator, now Vice President for Food and Agriculture of the Biotechnology Industry Organization (BIO).

Herceptin hype: Big Pharma's new "miracle cure" for breast cancer is inferior to free, natural cures Mike Adams, the Health Ranger See article keywords and concepts

Moss explained in a recent critical commentary published in New Scientist magazine (March 4, 2006), one of the main cheerleaders for Herceptin is none other than Hortobagyi, a paid consultant of genentech, who received somewhere between $10,000 and $100,000 from the drug company. He's one of the proponents who calls Herceptin a "cure." He probably even does it with a straight face. Is a 0.6% reduction in deaths really such a big deal?

Disease Prevention and Treatment The Life Extension Editorial Staff See book keywords and concepts

Trastuzumab (Herceptin genentech) Trastuzumab (Herceptin genentech) is an antineoplastic drug therapy for women with HER2-positive metastatic breast cancer. This monoclonal antibody therapy differs from traditional treatments, such as chemotherapy and hormone-blocking therapy. Herceptin works by specifically targeting tumor cells that overexpress the HER2 protein. A monoclonal antibody blocks the receptors and prevents activation of genes that induce cell division, thereby slowing the growth of the tumor.

More Natural Cures Revealed: Previously Censored Brand Name Products That Cure Disease Kevin Trudeau See book keywords and concepts

You may recognize some of the following names: Aventis, King Pharmaceuticals, Bristol-Myers Squibb, Bayer, GlaxoSmithKline, Novartis, Pfizer, Roche, Abbott Laboratories, genentech, Pharmacia, Astrazeneca, Natural-Source Vitamin E Association, and several others. These are the same companies that produce drugs that kill hundreds of thousands of people each year. Only these companies have the type of money that could fund such a study, representing their own interests, and not the public's. The next question is for what purpose was this study funded?

Disease Prevention and Treatment The Life Extension Editorial Staff See book keywords and concepts

Trastuzumab (Herceptin genentech) Trastuzumab (Herceptin genentech) is an antineoplastic drug therapy for women with HER2-positive metastatic breast cancer. This monoclonal antibody therapy differs from traditional treatments, such as chemotherapy and hormone-blocking therapy. Herceptin works by specifically targeting tumor cells that overexpress the HER2 protein. A monoclonal antibody blocks the receptors and prevents activation of genes that induce cell division, thereby slowing the growth of the tumor.

The Whistleblower: Confessions of a Healthcare Hitman Peter Rost See book keywords and concepts

For growth hormone this is a felony. genentech settled a similar case for their human growth hormone related to same issues during 1985-1994 for $50 million. Pharmacia sales reps who did not agree to off-label promotion were fired or other adverse action was taken against them. We also have compliance records from sales reps indicating in writing that they had been forced to do off-label promotion. Pharmacia also actively encouraged off-label prescriptions through favorable contracts with distributors and doctors exclusively working in the anti-aging area.

What's In Your Milk?: An Exposé of Industry and Government Cover-Up on the Dangers of the Genetically Engineered (rBGH) Milk You're Drinking Samuel S. Epstein, M.D. See book keywords and concepts

Genentech sold rBGH rights to Monsanto Co. 1982: Monsanto commenced long term milk production (efficacy) trials on cows injected daily with rBGH. In the same year, the FDA commenced review of Monsanto files on health effects of rBGH. 1985: With FDA approval, Monsanto initiated large-scale efficacy trials on rBGH, in close collaboration with indentured scientists in nationwide land grant Colleges and Universities, with sale of rBGH milk to the uninformed public.

Big Pharma: Exposing the Global Healthcare Agenda Jacky Law See book keywords and concepts

Dr Bob Mass, Genentech's director of bio-oncology, told Scrip Magazine there was a clear incentive to push the idea of people taking several drugs at once. 'More people on a double therapy could make a real impact on sales,' he said.26 What people are prepared to pay, on the other side of the equation, is almost impossible to know. The costs soon add up, however, if people take two or even three drugs at a time.

One of the reasons genentech, which is now 60% owned by Roche of Switzerland, has done well is that it takes risks to nurture cteativity. Napoleone Ferrara, Avastin's originating scientist, said he was only able to discover how new blood vessels grow to feed a turnout with nutrients because he had been given the time to do so,43 describing how it is company policy that a quarter of researchers' time should be spent on projects of their own choosing. Avastin's launch was the most successful in US oncology history, earning $545 million in its first ten months on the US market.

These drugs take medicine into a whole new pricing league. When genentech announced in February 2004 that Avastin would cost around $44,000 per patient per year, it was more than double some analysts' predictions.10 The price in the UK, at £24,000 ($43,200) per patient per year, either reflects a very strong pound or is very slightly cheaper. Erbitux costs $10,000 a month, meanwhile. These prices differ only marginally around the world. Then there are the actual gains to consider.

Seeds of Deception: Exposing Industry and Government Lies about the Safety of the Genetically Engineered Foods You're Eating Jeffrey M. Smith See book keywords and concepts

Some other strategic job swaps between the biotech industry and government: Genentech's David W. Beier became Vice President Al Gore's chief domestic policy advisor. Clayton K. Yeutter, former Secretary of Agriculture and former U.S. trade representative, became a member of Mycogen's board of directors. L. Val Giddings, Vice President of BIO, was biotechnology regulator and (biosafety) negotiator at the USDA. And Terry Medley, DuPont's director of regulatory and external affairs, held senior positions at the USDA and FDA. Leading figures in the George W.

Food, Inc. Mendel to Monsanto - The Promises and Perils of the Biotech Harvest Peter Pringle See book keywords and concepts

A few months later the stock price of the leading biotech firm, genentech, increased from thirty-five to eighty-nine dollars in twenty minutes during the company's initial stock offering—before the company had introduced a single product onto the market. Genes would become the "raw resource for future economic activity," observed Jeremy Rifkin.23 There was no immediate rush to patent plants, since breeders still had rights under the 1930 and 1970 acts.

Oxymorons: The Myth of a U.S. Health Care System J.D. Kleinke See book keywords and concepts

Back in 1993, when biotech company genentech was finally able to prove that its bioengineered clot-busting drug, Activase, improved mortality for heart attack patients by all of 1 percent (on an absolute basis), the drug, at $2,000 more per dose than streptokinase, its competing alternative, saw its market share increase from 50 to 66 percent.

Physician: Medicine and the Unsuspected Battle for Human Freedom Richard Leviton See book keywords and concepts

Virologists are "prominent," their experimental strategies are "working fantastically" their new vaccines are "quite effective" and "advanced," and top surgeons have "even attempted the daunting feat" of some new surgical intervention. A genentech scientist is "not discouraged" because biogenetics research is "explosive" and "promising." The Nobel Prize vindicates this rash of medical heroism: every new Nobel awarded further validates the paradigm.

The Cancer Industry Ralph W. Moss, Ph.D. See book keywords and concepts

TNF and other biological modifiers had begun to be produced in large quantities by several biotechnology companies, including genentech, Inc. and Biogen S.A. (Old, 1988). On a theoretical level, by 1985 Burton found himself practically in the mainstream of thinking—except he had had twenty years experience treating cancer patients with immunotherapy. But from another point of view Burton also became more dangerous, since he now had direct competitors at powerful, major centers. In mid-1985, Steven Rosenberg, M.D.

page 1 of 2 | Next ->

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalNews.com/np/index.html

This unique compilation of research is copyright (c) 2008 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of this NaturalNews Naturalpedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.